Maternus-Kliniken Aktiengesellschaft/€MAK
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Maternus-Kliniken Aktiengesellschaft
Maternus-Kliniken Aktiengesellschaft operates in the healthcare industry, focusing on providing medical and nursing care services. The company specializes in rehabilitation clinics, nursing homes, and residential facilities offering specialized care for various patient needs, from medical rehabilitation to long-term elderly care. Headquartered in Berlin, Germany, Maternus-Kliniken has developed a network of facilities across Germany, catering to diverse patient demographics. Its strategic positioning lies in its ability to integrate medical, therapeutic, and social care services, offering comprehensive solutions tailored to individual patient requirements. The firm leverages its expertise in healthcare management to maintain a competitive presence in the German market.
Ticker
€MAK
Sector
Primary listing
XETRA
Employees
1,426
Headquarters
Website
MAK Metrics
BasicAdvanced
€27M
-
-€0.63
0.49
-
Price and volume
Market cap
€27M
Beta
0.49
52-week high
€1.65
52-week low
€0.94
Financial strength
Current ratio
0.128
Quick ratio
0.093
Long term debt to equity
-72.971
Total debt to equity
-164.65
Interest coverage (TTM)
-0.47%
Profitability
EBITDA (TTM)
-0.773
Gross margin (TTM)
19.59%
Net profit margin (TTM)
-11.54%
Operating margin (TTM)
-3.50%
Effective tax rate (TTM)
-27.90%
Revenue per employee (TTM)
€80,000
Management effectiveness
Return on assets (TTM)
-1.69%
Return on equity (TTM)
22.51%
Valuation
Price to revenue (TTM)
0.235
Price to book
-0.41
Price to tangible book (TTM)
-0.34
Price to free cash flow (TTM)
1.937
Free cash flow yield (TTM)
51.63%
Free cash flow per share (TTM)
0.661
Growth
Revenue change (TTM)
11.43%
Earnings per share change (TTM)
-7.72%
3-year revenue growth (CAGR)
0.76%
10-year revenue growth (CAGR)
-0.68%
3-year earnings per share growth (CAGR)
72.55%
10-year earnings per share growth (CAGR)
-6.88%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Maternus-Kliniken Aktiengesellschaft stock?
Maternus-Kliniken Aktiengesellschaft (MAK) has a market cap of €27M as of August 23, 2025.
What is the P/E ratio for Maternus-Kliniken Aktiengesellschaft stock?
The price to earnings (P/E) ratio for Maternus-Kliniken Aktiengesellschaft (MAK) stock is 0 as of August 23, 2025.
Does Maternus-Kliniken Aktiengesellschaft stock pay dividends?
No, Maternus-Kliniken Aktiengesellschaft (MAK) stock does not pay dividends to its shareholders as of August 23, 2025.
When is the next Maternus-Kliniken Aktiengesellschaft dividend payment date?
Maternus-Kliniken Aktiengesellschaft (MAK) stock does not pay dividends to its shareholders.
What is the beta indicator for Maternus-Kliniken Aktiengesellschaft?
Maternus-Kliniken Aktiengesellschaft (MAK) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.